Table 5

Inter-relationships between the clinicopathological characteristics in patients with ER negative primary operable invasive ductal breast cancer (n = 124)
  Size   Grade Involved lymph node PR status HER-2 status Ki-67 status   LVI   MVD Loco-regional treatment Systemic treatment
( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value) ( P -value)
Age (≤50/>50 years) 0.241 0.908 0.242 0.002 0.154 0.772 0.826 0.347 0.282 0.059
Size (≤20/21-50/>50 mm) 0.181 0.004 0.131 0.343 0.085 0.011 0.106 0.042 0.151
Grade (I/II/III) 0.127 0.049 0.730 0.586 0.042 0.586 0.980 0.164
Involved lymph node (0/1-3/>3) 0.166 0.058 0.392 <0.001 0.068 0.013 0.118
Progesterone –receptor status (PR-/PR+) 0.769 0.985 0.111 0.191 0.093 0.272
HER-2 status (HER-2 -/HER-2+) 0.949 0.001 0.340 0.068 0.292
Ki-67 proliferative activity (Low Ki-67/High Ki-67) 0.739 0.651 0.256 0.335
LVI (Absent/Present) 0.414 0.054 0.563
MVD (tertiles 1, 2, 3) 0.020 0.944
Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy) 0.432

Bold data reflects an association between the two variables.

Mohammed et al.

Mohammed et al. BMC Clinical Pathology 2013 13:31   doi:10.1186/1472-6890-13-31

Open Data